NTRC 0066-0

CAS No. 1817791-73-3

NTRC 0066-0( —— )

Catalog No. M34353 CAS No. 1817791-73-3

NTRC 0066-0 is an orally available, selective and potent inhibitor of threonine tyrosine kinase (TTK) that inhibits phosphorylation of TTK substrates and induces chromosome missegregation in cell lines and mice for cancer research.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 142 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    NTRC 0066-0
  • Note
    Research use only, not for human use.
  • Brief Description
    NTRC 0066-0 is an orally available, selective and potent inhibitor of threonine tyrosine kinase (TTK) that inhibits phosphorylation of TTK substrates and induces chromosome missegregation in cell lines and mice for cancer research.
  • Description
    NTRC 0066-0 is a selective threonine tyrosine kinase (TTK) inhibitor (IC50=0.9 nM). NTRC 0066-0 can be used for the research of cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1817791-73-3
  • Formula Weight
    565.71
  • Molecular Formula
    C33H39N7O2
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 20.83 mg/mL (36.82 mM; Ultrasonic (<60°C)
  • SMILES
    O=C(NC=1C(=CC=CC1CC)CC)C=2C=CN3C4=NC(=NC=C4CCC23)NC5=CC=C(C=C5OC)N6CCN(C)CC6
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Uitdehaag JCM, et al. Target Residence Time-Guided Optimization on TTK Kinase Results in Inhibitors with Potent Anti-Proliferative Activity. J Mol Biol. 2017;429(14):2211-2230.?
molnova catalog
related products
  • 3-Methyladipic acid

    3-Methyladipic acid is a metabolite of the catabolism of phytanic acid. Patients with adult Refsums disease (ARD) are unable to detoxify phytanic acid by alpha-oxidation and so the w-oxidation pathway is the only metabolic pathway available for phytanic acid degradation.

  • DCLK1-IN-1

    DCLK1-IN-1 is a selective and in vivo-compatible chemical probe of the DCLK1 kinase domain .

  • (1S,2S)-1-(4-O-β-D-G...

    (1S,2S)-1-(4-O-β-D-Glucopyranosyl-3,5-dimethoxyphenyl)-2-[3-(4-O-β-D-glucopyranosyl-3,5-dimethoxyphenyl)-2-propen-1-yl]-1,3-propanediol